Key statistics
On Monday, Candel Therapeutics Inc (CADL:NMQ) closed at 5.11, 20.24% above the 52 week low of 4.25 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.06 |
|---|---|
| High | 5.20 |
| Low | 5.06 |
| Bid | -- |
| Offer | -- |
| Previous close | 5.25 |
| Average volume | 2.09m |
|---|---|
| Shares outstanding | 73.24m |
| Free float | 64.04m |
| P/E (TTM) | -- |
| Market cap | 384.53m USD |
| EPS (TTM) | -0.5591 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
- Candel Therapeutics Announces Pricing of Public Offering
- Candel Therapeutics Announces Proposed $100 Million Public Offering
- Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
- Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
- Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
- Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
More ▼
